Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novoste (novt) -- Ignore unavailable to you. Want to Upgrade?

To: Mike who wrote (82)	11/10/2000 11:38:51 PM
From: JMarcus	Read Replies (1) \| Respond to of 100

On Thursday, Ronald Garron, who publishes the Biotech Insight column on www.biospace.com, issued the following ringing endorsement of NOVT: >>Novoste and J&J recently got approval for intra-coronary radiation devices for in-stent stenosis. This is a huge market and can be rapidly expanded to the upfront treatment of all stented patients (balloon angioplasty and stenting is becoming the gold standard for certain coronary conditions) to prevent scarring. I like Novoste and believe they will walk away with the market (for Biotech Insight subscribers see the more detailed alert of 11/7/2000 in the archives).<< It is always nice to see others with some mutual enthusiasm. Marc